{"Title": "Tuberculosis vaccines: Time for a global strategy", "Year": 2015, "Source": "Sci. Transl. Med.", "Volume": "7", "Issue": 276, "Art.No": null, "PageStart": null, "PageEnd": null, "CitedBy": 53, "DOI": "10.1126/scitranslmed.aaa4730", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84923923821&origin=inward", "Abstract": "\u00a9 2015, American Association for the Advancement of Science. All rights reserved.We need a global strategy for the development of better tuberculosis vaccines.", "AuthorKeywords": null, "IndexKeywords": ["Clinical Trials as Topic", "Costs and Cost Analysis", "Humans", "Internationality", "Tuberculosis Vaccines"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-84923923821", "SubjectAreas": [["Medicine (all)", "MEDI", "2700"]], "AuthorData": {"9942450300": {"Name": "Kaufmann S.", "AuthorID": "9942450300", "AffiliationID": "60022344", "AffiliationName": "Departmentof Immunology, Max Planck Institute for Infection Biology"}, "7401453852": {"Name": "Evans T.", "AuthorID": "7401453852", "AffiliationID": null, "AffiliationName": "Aeras"}, "6603950018": {"Name": "Hanekom W.", "AuthorID": "6603950018", "AffiliationID": "60022241", "AffiliationName": "Bill and Melinda Gates Foundation"}}}